Skip to main content

BioVenture — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

279
Companies
$2.1B
Total invested
$23.9M
Avg. check
21
Industries
Biotechnology 16Health Care 10Medical 9Pharmaceutical 7Biopharma 6Therapeutics 4+15 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97–120 of 279
Theolytics
March 2026

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

Biotechnology · Oxford$9.3M Grant
Chromai
February 2026

Chromai offers high-performance intelligent liquid chromatography and medical diagnostic solutions.

Health Care · ShunyiSeries Unknown
Praeventix
February 2026

Praeventix is a biotechnology company developing therapeutics to treat bowel diseases.

Biotechnology · Exton$3.0M Series Unknown
LB Pharmaceuticals
February 2026

LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.

Biopharma · New York$100.0M Post Ipo Equity
NeuShen Therapeutics
January 2026

NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.

Biotechnology · ShanghaiSeries A
XellSmart
January 2026

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Biopharma · MinhangSeries C
Qinhao Pharmaceutical
January 2026

Qinhao Pharmaceutical is harmaceutical enterprises with a gathering of humanities and innovation.

Biotechnology · Suzhou$43.0M Series Unknown
Vivere Oncotherapies
January 2026

Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms.

Biotechnology · Berkeley$10.0M Seed
Cryofocus Biotech
January 2026

Cryofocus Biotech cryoablation device manufacturer.

Health Care · Shanghai$5.1M Post Ipo Equity
Essentia Biosciences
January 2026

Essentia Biosciences is a biotechnology company that specializes in development of cells, gene technology drugs and medical devices.

Biotechnology · Haidian$14.3M Seed
Jiajin Biotech
December 2025

Jiajin Biotech is a pharmaceutical R&D service provider.

Biopharma · PudongSeries B
Degron Therapeutics
December 2025

Degron Therapeutics is a platform company in discovery of molecular glue degraders for cancer treatment.

Biotechnology · ShanghaiSeries B
Lingtai Biotechnology
December 2025

Lingtai Biotechnology is a pharmaceutical and biotechnology based company that develops targeted protein degradation drugs.

Biotechnology · Shanghai$28.4M Series B
Allink Biotherapeutics
December 2025

Allink Biotherapeutics is a biopharmaceutical company that develops multi-specific antibodies for oncology and immunology treatment.

Biopharma · Shanghai$47.0M Series A
KYinno
December 2025

KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.

Biotechnology · Beijing$35.5M Series B
Afference
December 2025

Afference is an electronics manufacturing company that offers wearables that enable the digital dexterity of 3D digital content.

Consumer Electronics · Boulder$15.3M Series Unknown
Xingyuanzhi Robotics
December 2025

Xingyuanzhi Robotics is a company focused on the development of universal embodied brain technology.

Intelligent Systems · Beijing$14.2M Angel
Psivant Therapeutics
December 2025

Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.

Biopharma · Watertown$47.5M Series A
Hengyu Medical
December 2025

Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

Health Care · Tianjin$14.1M Series Unknown
AnyiPu
December 2025

AnyiPu is a leading Chinese high-tech company focused on chemical analysis and medical testing instruments.

Manufacturing · Suzhou$14.1M Series B
Help Therapeutics
December 2025

Developing Cell Therapies for Degenerative Diseases.

Biotechnology · NanjingSeries D
Reprogenix
November 2025

Reprogenix is a groundbreaking medical technology firm

Health Care · Hangzhou$70.3M Series A
Junsai Shengwu
November 2025

Junsai Shengwu is a biotechnology company that develops novel therapeutic approaches for new solid tumor cell .

Biopharma · Shanghai$19.2M Series C
Shenzhen CardioACC Ltd
October 2025

Shenzhen CardioACC Ltd specializes in advanced cardiovascular interventional, natural cavity imaging and advanced diagnostic procedures.

Biotechnology · Shenzhen$14.1M Series A

Where BioVenture invests

Biotechnology16
Health Care10
Medical9
Pharmaceutical7
Biopharma6
Therapeutics4

About BioVenture's portfolio

How many companies has BioVenture invested in?▸

BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BioVenture invest in?▸

BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Biopharma. The firm invests across 21 different industry categories.

What is BioVenture's largest investment?▸

Among tracked funding rounds, LB Pharmaceuticals received $100.0M in a Post Ipo Equity round. BioVenture's total known invested capital is $2.1B.

What is the average investment size for BioVenture?▸

BioVenture's average investment size is $23.9M across its portfolio of 279 companies.

What are BioVenture's most recent investments?▸

Recent BioVenture portfolio additions include Theolytics, Chromai, Praeventix, LB Pharmaceuticals, NeuShen Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 279 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →